Peter Linde - Sep 16, 2021 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role: Chief Medical Officer
Signature: /s/ Robert Farrell as attorney-in-fact for Peter Linde
Stock symbol: MORF
Transactions as of: Sep 16, 2021
Transactions value $: -$266,037
Form type: 4
Date filed: 9/17/2021, 07:04 PM
Previous filing: Jun 3, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MORF	Common Stock	Options Exercise		+10.4K	+212.06%		15.3K	Sep 16, 2021	Direct	F1, F2
transaction	MORF	Common Stock	Sale	-$6.43K	-100	-0.65%	$64.29	15.2K	Sep 16, 2021	Direct	F3
transaction	MORF	Common Stock	Sale	-$218K	-3.28K	-21.59%	$66.48	11.9K	Sep 16, 2021	Direct	F3, F4
transaction	MORF	Common Stock	Sale	-$41.8K	-624	-5.25%	$67.00	11.3K	Sep 16, 2021	Direct	F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MORF	Restricted Stock Unit (RSU	Options Exercise	$0	-10.4K	-100%	$0.00^*	0	Sep 16, 2021	Common Stock	10.4K		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F2	Includes 294 shares of Common Stock acquired under the issuer's employee stock purchase plan on August 31, 2021.
F3	Represents the aggregate number of shares sold by the reporting person to cover taxes and fees due upon the release and settlement of the RSUs. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
F4	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.89 to $66.8825 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.915 to $67.105 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6	The RSU vests 50% on March 16, 2021 and the remaining 50% vests on September 16, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.